Sara Sarraf, MD
Obstetrics & Gynecology · Midlothian, VANPI 1184850646
Payments from drug & device makers
Across 62 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$298
- Bayer$141
- Biogen$100
- Sumitomo Pharma America, Inc.$75
- Mayne Pharma Commercial LLC$73
- Myriad Women's Health, Inc.$71
- plus $478 from 16 others
What the payments were for
- Food & beverage$1,21999%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $298 |
| Bayer | 9 | $141 |
| Biogen | 4 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $75 |
| Mayne Pharma Commercial LLC | 4 | $73 |
| Myriad Women's Health, Inc. | 1 | $71 |
| Astellas Pharma US Inc | 3 | $65 |
| Agile Therapeutics, Inc. | 4 | $60 |
| Exeltis, USA Inc. | 4 | $51 |
| Urovant Sciences Inc | 2 | $42 |
| Myovant Sciences Inc. | 2 | $30 |
| Boston Scientific | 1 | $29 |
| Organon | 2 | $28 |
| Mylan Pharmaceuticals Inc. | 1 | $27 |
| Therapeuticsmd, Inc. | 2 | $25 |
| Coopersurgical, Inc. | 1 | $23 |
| Pfizer | 1 | $19 |
| Merck | 1 | $17 |
| AMAG Pharmaceuticals, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
How this compares
$1,236 in reported general payments places this provider in the 65th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $1,635 |
| Clobetasol Propionate | 19 | $763 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Midlothian
- Franklin MorganNorfolk$3.6M
- Samuel CampbellRichmond$1.5M
- Thomas KimbleNorfolk$1M
- Camilla HershReston$912K
- Stephen PoundNorth Chesterfield$548K
- Prescott PrillamanRichmond$329K
- Jack AyoubLeesburg$286K
- Chul KimFalls Church$250K
- Kurian ThottStafford$216K
- John PartridgeRichmond$216K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.